Home › Down Syndrome › Michigan
Down Syndrome clinical trials in Michigan
7 studies for Down Syndrome are looking for participants at sites in Michigan.
Cities in Michigan
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- University of Michigan, Ann Arbor
Recruiting
Ages 2 to 17 · All sexes · Updated Sep 11, 2026 · NCT05508971Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
- Henry Ford Hospital, Detroit
- Spectrum Health, Grand Rapids
RecruitingObservational study
Ages 18 and older · Women · Updated Sep 9, 2026 · NCT01429389A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- C S Mott Children's Hospital, Ann Arbor
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Bronson Methodist Hospital, Kalamazoo
- and 1 more
RecruitingPhase 2
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- and 1 more
RecruitingObservational study
Ages 6 to 39 · All sexes · Updated Aug 25, 2026 · NCT05702645Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- The University of Michigan, Ann Arbor
Recruiting
Ages 3 to 21 · All sexes · Updated Aug 19, 2026 · NCT05527652How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome
- Michigan State University, East Lansing
Recruiting
Ages 2 to 7 · All sexes · Updated Jun 12, 2026 · NCT06951516Down Syndrome Obstructive Sleep Apnea
- University of Michigan, Ann Arbor Hospital, Ann Arbor
RecruitingPhase 2
Ages 5 to 18 · All sexes · Updated Apr 20, 2025 · NCT06043440From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.